Novo Nordisk Launches Wegovy Pill in UAE, First Market Outside U.S

• UAE selected as first international market due to strong momentum in patient demand, healthcare readiness, and telehealth infrastructure
• Novo Nordisk plans to expand the Wegovy pill to additional select countries in coming months beyond UAE and U.S. markets
• Launch decision guided by Emil Kongshøj Larsen, executive vice president of International Operations

Summary: Novo Nordisk Expands Wegovy Pill to UAE Market

Key Development:

Novo Nordisk announced Wednesday the launch of its weight loss pill Wegovy in the United Arab Emirates, marking the medication's first international expansion beyond the United States.

Strategic Rationale:

According to Emil Kongshøj Larsen, Executive Vice President of International Operations, the UAE was selected based on three critical factors:

• Strong patient demand
• Healthcare professional readiness
• Robust healthcare and telehealth infrastructure

The company indicated the UAE demonstrates "strong momentum" across all these areas, making it an ideal initial market for international expansion.

Market Implications:

This launch represents a significant milestone in Novo Nordisk's global weight loss strategy, with the Danish drugmaker planning to bring the Wegovy pill to additional select countries in the coming months. The company had previously announced plans for international expansion alongside its earnings report but had not specified target markets at that time.

Sector Context:

The weight loss pharmaceutical market has seen explosive growth, with GLP-1 medications like Wegovy becoming blockbuster products. This strategic international rollout suggests Novo Nordisk is moving aggressively to capture market share in high-potential regions with adequate healthcare infrastructure to support premium pharmaceutical products.

The measured, selective approach to international expansion—focusing on markets with established healthcare systems and strong telehealth capabilities—indicates the company is prioritizing successful implementation over rapid geographic spread. Additional country launches are expected in the near term, though specific markets and timelines were not disclosed.